Company News: Boehringer Ingelheim

Share this article:
The Boehringer Ingelheim-backed Drive4COPD awareness campaign is getting a big response through its use of social media, the company said. The campaign, which launched two weeks ago, has generated 27,000 completions of a validated five-question screener available at Drive4COPD.com, along with 1,400 Facebook fans, 25,000 clicks on campaign images at photo sharing site Flickr, 140,000 search results and 14,500 Twitter followers who've been exposed to some 50 Tweets from the campaign's celebrity ambassadors.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Illumina inks deal with J&J, AstraZeneca, Sanofi

The goal is to develop companion diagnostics to match patients with cancer treatments.

Abbott deal highlights inversion inaction

Political furor over the recent spate of tax inversions is having little influence on how the government chooses its partners.

Allergan reported to seek out Salix deal

The Wall Street Journal says the deal would add "another layer of intrigue" to the Allergan-Valeant hostilities.